Synthesis and biological evaluation of some differently substituted 9,10-anthracenediones.

[1]  S. Moro,et al.  New 1,4-anthracene-9,10-dione derivatives as potential anticancer agents. , 2000, Farmaco.

[2]  M. Palumbo,et al.  NEW PEPTIDYL-ANTHRAQUINONES : SYNTHESIS AND DNA BINDING , 1998 .

[3]  E. Uriarte,et al.  Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. , 1996, Journal of medicinal chemistry.

[4]  E. Uriarte,et al.  Mass Spectrometric Investigation of 9,10-Anthracenedione Derivatives , 1995 .

[5]  C. Jagannath,et al.  Enhancement of drug susceptibility of multi-drug resistant strains of Mycobacterium tuberculosis by ethambutol and dimethyl sulphoxide. , 1995, Journal of Antimicrobial Chemotherapy.

[6]  H. Tomioka,et al.  In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins , 1991, Antimicrobial Agents and Chemotherapy.

[7]  J. Galgiani,et al.  Collaborative investigation of variables in susceptibility testing of yeasts , 1990, Antimicrobial Agents and Chemotherapy.

[8]  J. Lown,,et al.  Anthracycline and anthracenedione-based anticancer agents , 1988 .

[9]  J. R. Brown,et al.  Evidence for human liver mediated free-radical formation by doxorubicin and mitozantrone. , 1985, Anti-cancer drug design.

[10]  J. R. Brown,et al.  Trypanocidal activity of daunorubicin and related compounds , 1981, Nature.

[11]  J. Williamson,et al.  Trypanocidal Activity of Antitumor Antibiotics and Other Metabolic Inhibitors , 1978, Antimicrobial Agents and Chemotherapy.

[12]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[13]  Joseph F. Bunnett,et al.  Aromatic Nucleophilic Substitution Reactions. , 1951 .